![Andrey Mladentsev](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrey Mladentsev
Keine laufenden Positionen mehr
Profil
Healthcare professional.
Former VP CIS & Baltics at Stada, CEO at Promomed, CEO at NizhPharm (acquired by Stada), CEO at OBL Pharm (acquired by AFK Sistema).
Ehemalige bekannte Positionen von Andrey Mladentsev
| Unternehmen | Position | Ende |
|---|---|---|
| STADA ARZNEIMITTEL | Private Equity Investor | 01.03.2007 |
V12 Venture Israel MC Ltd.
 V12 Venture Israel MC Ltd. Investment ManagersFinance V12 Venture Israel invests in companies located in Israel. The firm focuses on companies operating in the fields of deep technology services. It provides financing for seed and early stage capital requirements. | Berater | - |
Ausbildung von Andrey Mladentsev
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
4
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
STADA Arzneimittel AG
 STADA Arzneimittel AG Pharmaceuticals: GenericHealth Technology Manufactures generic drugs and pharmaceuticals | Health Technology |
IEDC Bled School of Management
 IEDC Bled School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
V12 Venture Israel MC Ltd.
V12 Venture Israel MC Ltd. Investment ManagersFinance V12 Venture Israel invests in companies located in Israel. The firm focuses on companies operating in the fields of deep technology services. It provides financing for seed and early stage capital requirements. | Finance |
